Loading stock data…
Intuitive Surgical, Inc. (ISRG)
$405.97+1.70 (+0.42%)
Market ClosedLast close Jun 29
Intuitive Surgical, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Intuitive Surgical, Inc. in the Healthcare sector is trading at $405.97 with a market capitalization of $144.2B. Wall Street consensus targets $565.08 (29 analysts), implying a +39.2% move over the next 12 months. The stock is currently near its 52-week low of $396.68, remaining 17.0% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 90/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +39.2% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.77B↓ | $2.87B↑ | $2.51B↑ | $2.44B↑ | $2.25B |
| Gross Profit | $1.83B↓ | $1.90B↑ | $1.66B↑ | $1.62B↑ | $1.46B |
| Operating Income | $855.30M↓ | $864.30M↑ | $759.70M↑ | $743.40M↑ | $578.10M |
| Net Income | $821.50M↑ | $794.80M↑ | $704.40M↑ | $658.40M↓ | $698.40M |
Peer Comparison
JNJUNHPFE
Fundamentals
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Sur...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$144.25B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
49.37
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.51
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
17.05%
Volume
Today's trading volume
2.23M
Recent News
Can ISRG's 'Quintuple Aim' Strategy Continue to Justify Premium Pricing?
Intuitive Surgical's Quintuple Aim strategy is driving premium pricing as da Vinci 5 adoption grows, with innovation-led revenue growth outpacing procedure growth.
Intuitive Surgical Stock Is Up Over 400%. Here's Why It's Still a No-Brainer Buy.
Intuitive Surgical has been a huge winner over the long term, but there's a potential opening for new investors right now.
Intuitive Surgical, Inc. (ISRG) Rises As Market Takes a Dip: Key Facts
In the closing of the recent trading day, Intuitive Surgical, Inc. (ISRG) stood at $404.27, denoting a +1.14% move from the preceding trading day.
Piper Sandler Highlights Intuitive Surgical (ISRG) on Long-Term Growth Catalysts
Intuitive Surgical, Inc. (NASDAQ:ISRG) ranks among the best set-it-and-forget-it stocks to buy right now. On June 2, Piper Sandler restated its Overweight rating and $580 target on Intuitive Surgical, Inc. (NASDAQ:ISRG). The firm’s recent field check with the head of robotics at a prominent U.S. healthcare institution confirmed the firm’s positive opinion of the company. […]
Intuitive Surgical (ISRG) Faces Reuse Questions As Goldman Sachs Backs Fundamentals
Goldman Sachs and several industry analysts have publicly backed Intuitive Surgical's core business, following concerns about new rules on instrument reuse. The commentary argues that regulatory driven changes to reuse policies are unlikely to cause major disruption to Intuitive Surgical's revenue model. The defense comes after a period of share price pressure and renewed debate about the long term outlook for NasdaqGS:ISRG. Intuitive Surgical enters this debate with its stock under...